DISSOLUTION ENHANCEMENT OF ENTACAPONE FROM FIXED DOSE COMBINATION TABLETS LEVODOPA/CARBIDOPA/ENTACAPONE WITH MICROENVIRONMENTAL PH MODIFICATION TECHNIQUES
Entacapone is a catechol nitro compound used in the treatment of Parkinson's disease in combination with carbidopa and levodopa. Entacapone is classified in Biopharmaceutical Classification System (BCS) 4, with low solubility and membrane permeability. Based on this, entacapone needs to b...
Saved in:
Main Author: | Khairun Nisak, Rahmita |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/73968 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeys
by: Lyras, L., et al.
Published: (2013) -
THE EFFECT OF PH AND VARIOUS SURFACTANTS TO THE DISSOLUTION RATE OF GLIBENCLAMIDE TABLET
by: Baskaran, Narasimman -
Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets
by: Thomas Pouplin, et al.
Published: (2018) -
Contribution of the microenvironmental niche to glioblastoma heterogeneity
by: Ho, I.A.W, et al.
Published: (2020) -
Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria
by: Walter R.J. Taylor, et al.
Published: (2018)